Silver Book Fact

The number of cases of visual impairment and blindness from age-related macular degeneration (AMD0 is projected to increase from 620,000 in 2010 to 1.6 million in 2050–assuming no treatments.

Rein, David. B., John S. Wittenborn, Xinzhi Zhang, Amanda A. Honeycutt, Sarah B. Lessene, and Jinan Saadine; for the Vision Health Cost-Effectiveness Study Group. Forecasting Age-Related Macular Degeneration Through the Year 2050. Arch Ophthalmol. 2009; 127(4): 533-40. http://jama.ama-assn.org/content/301/20/2152.extract

Reference

Title
Forecasting Age-Related Macular Degeneration Through the Year 2050
Publication
Arch Ophthalmol
Publication Date
2009
Authors
Rein, David. B., John S. Wittenborn, Xinzhi Zhang, Amanda A. Honeycutt, Sarah B. Lessene, and Jinan Saadine; for the Vision Health Cost-Effectiveness Study Group
Volume & Issue
Volume 127, Issue 4
Pages
533-40
URL
Read Full Resource

Categories

  • Cost of Disease
  • Future Human Burden

Related Facts

  • People Affected Worldwide by DR
    By 2030, more than 191 million people around the world will be affected by DR—56 million with vision-threatening DR.  
  • More than 2.7 million Americans age 40 and older have glaucoma—2,719,379.  
  • Adults 60 years and older are 6 times more likely to develop glaucoma.  
  • Various studies found between 13% and 24% of age-related macular degeneration (AMD) patients had experienced visual hallucinations.  
  • The annual direct medical costs (including outpatient, inpatient, and prescription drug services) for Americans age 40 and older with glaucoma is $2.86 billion.